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Abstract Flavonoid and isoflavonoid glycosides are common
dietary phenolics which may be absorbed from the small intestine
of humans. The ability of cell-free extracts from human small
intestine and liver to deglycosylate various (iso)flavonoid glyco-
sides was investigated. Quercetin 4P-glucoside, naringenin 7-
glucoside, apigenin 7-glucoside, genistein 7-glucoside and daid-
zein 7-glucoside were rapidly deglycosylated by both tissue
extracts, whereas quercetin 3,4P-diglucoside, quercetin 3-gluco-
side, kaempferol 3-glucoside, quercetin 3-rhamnoglucoside and
naringenin 7-rhamnoglucoside remained unchanged. The Km for
hydrolysis of quercetin 4P-glucoside and genistein 7-glucoside was
V32 þ 12 and V14 þ 3 WM in both tissues respectively. The
enzymatic activity of the cell-free extracts exhibits similar
properties to the cytosolic broad-specificity L-glucosidase pre-
viously described in mammals.
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1. Introduction
Flavonoids are polyphenolic compounds found abundantly
in plants, which may play a dietary role in reducing the risk
from chronic diseases such as cardiovascular disease and can-
cer [1^3]. The £avonoids exist in nature almost exclusively as
L-glycosides. The £avonols are found mainly as the 3-O-glyco-
side, although the 7 and 4P positions may also be glycosylated
in some plants, e.g. onions [4]. Other classes of £avonoids,
such as the £avones, £avanones and iso£avones, are found
mainly glycosylated in the 7 position [5]. The basic structure
of the (iso)£avonoids with positions of glycosylation are
shown in Fig. 1.
Flavonoid glycosides are mostly unmodi¢ed by various
cooking methods [6], although the aglycone is released by
fermentation and processes involving autolysis [7]. Thus, in
general, food when consumed has a low level of aglycone
compared to the glycosides. Until recently it has been as-
sumed that the glycosides cannot be absorbed from the small
intestine and cleavage of the L-glycoside linkage will not occur
until the compounds reach the micro£ora in the large intestine
[8]. Some evidence now exists for the preferential uptake of
onion £avonol glycosides from the small intestine compared
to the aglycone [9,10]. In vitro uptake of genistein 7-glucoside
across Caco-2 cells in culture has also been shown [11]. There
is little evidence to suggest how these £avonoid glycosides
would be metabolized by tissues, as most human studies on
the absorption and metabolism of £avonoids from foods have
involved hydrolysis of the samples to the aglycones prior to
analysis.
Biological activity depends on the presence or absence of
the glycoside residue [12]. The position and nature of the
sugar residue may increase the uptake of the compound in
the small intestine. However, the aglycone is likely to have a
greater biological e¡ect than the glycoside [12], so deglycosyl-
ation via a L-glucosidase activity would be an important step
in metabolism.
Three native L-glucosidase enzymes have been identi¢ed in
humans [13]. Two of these, the glucocerebrosidase (EC
3.2.1.62) and lactase phlorizin hydrolase (EC 3.2.1.108), are
membrane-bound and have been shown to have speci¢c sub-
strate activities. The former is a lysosomal enzyme which hy-
drolyses glucoceramide from endogenous membrane glycolip-
ids; de¢ciency in this enzyme is associated with Gaucher
disease [13]. Lactase phlorizin hydrolase is a membrane-bound
enzyme found in the brush-border of the small intestine, and
is primarily responsible for hydrolysis of lactose; de¢ciency of
this enzyme causes lactose-intolerance [14]. Lactase phlorizin
hydrolase also has a second hydrophobic domain which is
capable of hydrolyzing phlorizin to phloretin and glucose
[15]. The third L-glucosidase is a broad-speci¢city cytosolic
enzyme found in abundance in the liver, kidney and small
intestine of mammals [16,17].
The broad-speci¢city L-glucosidase is thought to play a role
in detoxifying xenobiotics by hydrolyzing the L-glucoside moi-
ety to provide a site for conjugation, which would lead to
rapid excretion in the bile and urine. Several naturally occur-
ring compounds have been shown to be substrates for this
broad-speci¢city enzyme [18,19]. A high speci¢city was also
shown towards L-glucose residues on steroids such as estradiol
by rabbit L-glucosidase [16,20]. Pyridoxine 5P-L-glucoside is
hydrolyzed to pyridoxine, which is the major active form of
vitamin B6, by a cytosolic L-glucosidase present in the small
intestine, liver and kidneys of humans [21]. Recently another
cytosolic L-glucosidase has been identi¢ed in porcine jejunal
mucosa [22] which is speci¢c for pyridoxine glucoside and
may be responsible for the activity found previously in human
tissue.
The aims of this study are to use human small intestine and
liver cell-free extracts to show whether there is L-glucosidase
activity towards (iso)£avonoid glycosides. By using known
inhibitors, we show that the high activity present in human
small intestine and liver cell-free extracts is likely to be attrib-
uted to the cytosolic broad-speci¢city L-glucosidase.
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2. Materials and methods
2.1. Chemicals
All reagents were purchased from Sigma (Poole, Dorset, UK) and
were of analytical reagent grade or HPLC grade where applicable.
Quercetin 4P-glucoside (Q 4P-glu) and quercetin 3,4P-diglucoside
(Q 3,4P-glu) were extracted and puri¢ed (s 99% purity) from onion
bulb tissue [23]. Quercetin 3-glucoside (Q 3-glu), kaempferol 3-gluco-
side (K 3-glu), daidzein 7-glucoside (daidzin), apigenin 7-glucoside
and naringenin 7-glucoside were purchased from Apin Chemicals
(Abingdon, Oxon, UK). Quercetin 3-rhamnoglucoside (rutin), narin-
genin 7-rhamnoglucoside (naringin), and genistein 7-glucoside (genis-
tin) were obtained from Sigma. All (iso)£avonoids were checked for
purity by HPLC prior to use. Water was puri¢ed via a Millex Q-plus
system (Millipore, Watford, UK).
2.2. Preparation of £avonoids
All £avonol glycosides were dissolved in methanol and stored at
4‡C. Immediately prior to the reaction, an aliquot was dried by rotary
evaporation and redissolved in dimethyl sulphoxide (DMSO) and po-
tassium phosphate bu¡er (10 mM, pH 7), to give a ¢nal DMSO
concentration of less than 0.2% (v/v) in the reaction mixture. Fla-
vones, £avanones and iso£avones were dissolved in DMSO and stored
at 4‡C. As above, an aliquot was diluted in phosphate bu¡er to give a
¢nal DMSO concentration of less than 0.2% (v/v) in the reaction
mixture. Standard curves were calculated for each (iso)£avonoid gly-
coside and corresponding aglycone.
2.3. Preparation of cell-free extracts
Samples of small intestine and liver were obtained from redundant
tissue of surgical specimens from patients undergoing gastrointestinal
surgery. The study was approved by the Norwich District Ethics
Committee and carried out in accordance with the Declaration of
Helsinki of the World Medical Association. The patients gave in-
formed consent to the work. Samples were immediately cut into por-
tions (V0.1 g) for storage at 370‡C until required. On three occa-
sions the tissue samples were prepared and used within 4 h of surgery.
Each tissue sample was homogenized in ice-cold phosphate bu¡er
(1 ml), containing 2-mercaptoethanol (10 mM), followed by centrifu-
gation at 13 600Ug, 4‡C for 30 min. The supernatant was retained
and stored on ice prior to use.
2.4. Enzyme assay
Each £avonoid glycoside was mixed with liver or small intestine
extract (containing 200 Wg protein) and phosphate bu¡er, to give a
¢nal £avonol concentration of 30 WM in 0.5 ml. Samples were incu-
bated at 37‡C for up to 90 min, with controls of heat-inactivated
(100‡C, 5 min) tissue extract run in parallel. The reaction was stopped
by addition of methanol (0.5 ml), containing 0.8 mM ascorbic acid to
stabilize the samples during analysis, followed by centrifugation at
13 600Ug, for 10 min at 4‡C. The supernatant was ¢ltered through
0.22 Wm PTFE ¢lter units (HPLC Technology Company, Maccles-
¢eld, UK) and analyzed by HPLC.
2.5. Calculation of Km and Vmax
Various concentrations of Q 4P-glu and genistin were mixed with
aliquots (25 Wl) of small intestine or liver extract and phosphate bu¡er
to a ¢nal volume of 0.5 ml. All samples were incubated at 37‡C for a
time period during which the reaction was linear (liver samples,
15 min; small intestine samples, 5 min). The reaction was stopped
with methanol/ascorbic acid and treated as described above for
HPLC analysis. Protein was determined according to the Bradford
method [24], using bovine serum albumin as standard. Km and the
apparent Vmax were computed using a method described by Wilkinson
[25].
The e¡ect of various inhibitors of L-glucosidases was investigated
[17]. D-gluconolactone, sodium taurocholate and conduritol B epoxide
were incubated at various concentrations with aliquots (50 Wl) of liver
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Fig. 1. Structure of £avonoid and iso£avonoid glycosides.
Table 1
Initial rates and extent of deglycosylation of (iso)£avonoid glycosides with a small intestine and liver cell-free extract
Substrate Initial rate of deglycosylation Deglycosylation after 90 min
(Wmol/min mg) (%)
Small intestine Liver Small intestine Liver
Q 4P-glucoside 2.14 þ 0.20 0.74 þ 0.02 90.0 þ 1.3 68.7 þ 0.1
Q 3-glucoside 0.14 þ 0.03 0 16.2 þ 0.5 0
Q 3-rhamnoglucoside 0 0 0 0
Q 3,4P-diglucoside 0 0 0 0
K 3-glucoside 0 0 0 0
Genistein 7-glucoside 3.15 þ 0.22 1.06 þ 0.22 97.8 þ 0.5 76.3 þ 0.4
Daidzein 7-glucoside 2.40 þ 0.15 0.54 þ 0.06 95.0 þ 0.8 66.5 þ 0.3
Apigenin 7-glucoside 1.35 þ 0.20 0.61 þ 0.13 83.3 þ 0.2 49.0 þ 0.9
Naringenin 7-glucoside 1.05 þ 0.17 0.30 þ 0.09 66.1 þ 2.8 26.3 þ 0.6
Naringenin 7-rhamnoglucoside 0 0 0 0
Samples were incubated for various time intervals (0^90 min) at 37‡C. Initial rates were calculated using the linear component of the progress curve
only. Alternate time points were assayed in triplicate.
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or small intestine extract, glycoside (30 WM) and phosphate bu¡er to a
¢nal volume of 0.5 ml. Each sample was incubated at 37‡C for 15 min.
The reaction was stopped with methanol/ascorbic acid and treated as
described above for HPLC analysis.
2.6. HPLC analysis
A modi¢ed version of the analytical HPLC method of Price et al.
[26] was used. Solvents A (water:tetrahydrofuran:tri£uoroacetic acid,
98:2:0.1) and B (acetonitrile), were run at a £ow rate of 1 ml/min,
using a gradient of 17% B (2 min), increasing to 25% B (5 min), 35%
B (8 min), 50% B (5 min) and then to 100% B (5 min). A column
clean-up stage maintained B at 100% (5 min) followed by a re-equil-
ibration at 17% B (15 min). The column was packed with Prodigy
5 Wm ODS3 reverse-phase silica, 250 mm by 4.6 mm id (Phenomenex,
Maccles¢eld, UK). Diode array detection monitored the e¥uent at
270 and 370 nm.
3. Results
Fig. 2 shows representative chromatograms from 0, 30 and
90 min incubations of Q 4P-glu with a cell-free small intestine
extract, demonstrating the conversion of Q 4P-glu to quercetin
by hydrolysis of the L-glucoside bond. Table 1 shows the rate
of deglycosylation of various £avonoid glycosides by a cell-
free extract from human small intestine and liver containing
equivalent total protein. Q 4P-glu, apigenin 7-glucoside, nar-
ingenin 7-glucoside, daidzin, and genistin are all hydrolyzed
by the hepatic or intestinal enzymes. The rate of deglycosyla-
tion in these samples suggests that the small intestine is more
active in this hydrolysis than the liver. Q 3-glu, Q 3,4P-glu, K
3-glu, rutin and naringin are not hydrolyzed by the enzymes
from the liver extract in a 90 min period, and with the ex-
ception of a small quantity of the Q 3-glu, these compounds
are not hydrolyzed by the small intestine extract either. A
similar pattern of deglycosylation was seen in all liver and
small intestine samples analyzed, with no di¡erences between
the freshly prepared and frozen samples.
L-Glucosidase activity at various concentrations of Q 4P-glu
and genistin was measured in both the small intestine and
liver extracts. The Km and apparent Vmax of the reactions
were calculated for each tissue sample, based on the rate of
formation of the aglycone, and the average values are shown
in Table 2. The results suggest that the same enzyme, or one
with very similar properties, is responsible for catalyzing
the reaction in the liver and small intestine, with a Km of
V32 WM for Q 4P-glu and V14 WM for genistin. The total
amount of the L-glucosidase activity varies between individu-
als, although it would appear that the rate of reaction is in
general faster in the small intestine than in the liver. This
would indicate that the intestinal mucosa plays an important
role in the deglycosylation of £avonoids during absorption.
To determine which enzyme was responsible for this activity
we used three inhibitors of the human cytosolic broad-specif-
icity L-glucosidase or the membrane-bound glucocerebrosid-
ase [17]. These inhibitors have also been used to characterize
the di¡erences between pyridoxine glucoside hydrolase and
the broad-speci¢city L-glucosidase [22].
(1) D-gluconolactone is an inhibitor of both the cytosolic
and membrane-bound L-glucosidases, although it is much
more potent on the cytosolic enzyme at micromolar concen-
trations.
(2) Sodium taurocholate (1.2%, w/v) enhances the activity
of the membrane-bound L-glucosidase, but inhibits both the
broad-speci¢city and pyridoxine glucoside hydrolase. At 0.1%
(w/v), sodium taurocholate inhibits the broad-speci¢city L-glu-
cosidase by 50%, whereas little inhibition of pyridoxine gluco-
side hydrolase is seen at this concentration.
(3) Conduritol B epoxide (6.2 mM) has little e¡ect on the
broad-speci¢city L-glucosidase, but shows complete inhibition
of glucocerebrosidase at this concentration. Conduritol B ep-
oxide inhibits pyridoxine glucoside hydrolase by 70% at 5 mM.
In our experiments, both D-gluconolactone and sodium
taurocholate exhibited an inhibitory e¡ect on the L-glucosid-
FEBS 20863 25-9-98
Table 2
Km and apparent Vmax of Q 4P-glucoside and genistein 7-glucoside by cytosolic L-glucosidase from human small intestine and liver cell-free ex-
tracts
Substrate Liver Small intestine
Q 4P-glucoside Km (WM) 27 þ 13 (n = 7) 37 þ 12 (n = 4)
Vmax (mU/mg protein) 0.35^1.38 1.06^1.51
Genistein 7-glucoside Km (WM) 13 þ 1 (n = 3) 14 þ 5 (n = 3)
Vmax (mU/mg protein) 1.03^1.34 1.50^2.91
One unit of activity is de¢ned as one Wmol of product formed per min at 37‡C. Km values are expressed as mean þ standard deviation, whereas Vmax
is shown as the range of values measured.
Fig. 2. HPLC chromatogram, monitoring relative absorbance at 370
nm, of Q 4P-glu (30 WM) after incubation with small intestine ex-
tract (200 Wg protein), at 37‡C for (a) 0 min, (b) 30 min, (c) 90
min.
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ase activity as shown in Table 3. In addition, sodium tauro-
cholate caused 60% inhibition at 0.2% (w/v). The L-glucosid-
ase activities of the small intestine and liver extracts were
inhibited by V5 and 17% respectively by conduritol B epox-
ide (5 mM). The e¡ects of these inhibitors are in general
agreement with Daniels et al. [17] and suggests that the L-
glucosidase reaction is carried out by the cytosolic broad-spe-
ci¢city L-glucosidase.
4. Discussion
This study shows that human small intestine and liver have
a L-glucosidase capable of e⁄ciently hydrolyzing various nat-
urally occurring £avonoid and iso£avonoid glycosides. This
enzyme has a relatively high a⁄nity for Q 4P-glu as a sub-
strate. The small intestine L-glucosidase was also capable of
slowly hydrolyzing Q 3-glu, although the liver was not. Both
the hepatic and intestinal L-glucosidases were not active on
the exolytic rhamnose of rutin and more surprisingly, the 4P-
glucose from Q 3,4P-glu. Therefore, either Q 3-glu and Q 3,4P-
glu do not ¢t into the active site of the enzymes, or they bind
to form a non-productive complex. The small intestine may
have an additional enzyme which has a low activity towards
Q 3-glu, although whether this reaction is of physiological
importance, due to the short transition time in the intestinal
mucosa, is questionable.
Dietary £avonols are more frequently found with a sugar
attached in the 3 position, compared to the 7 and 4P positions.
Other types of £avonoids, which are devoid of a hydroxyl
group at position 3, are glycosylated mainly in the 7 position.
We therefore investigated the speci¢city of the L-glucosidase
activity from the small intestine and liver for other naturally
occurring 7-glycosylated £avonoids. The iso£avone, £avone
and £avanone 7-glucosides were all substrates for the L-glu-
cosidase, in contrast to naringin, a 7-rhamnoglucoside. The L-
glucosidase had a higher apparent a⁄nity towards genistein 7-
glucoside than quercetin 4P-glucoside. Table 4 shows the pub-
lished Km values for various L-glycoside substrates with liver
cytosolic L-glucosidase. The L-glucosidase in human liver has
a higher a⁄nity for the £avonoid and iso£avonoid glycosides
than for the other dietary compounds previously investigated
and, therefore, these compounds could be substrates in vivo
for this enzyme.
Only three human L-glucosidases have been reported to
date, with a fourth enzyme identi¢ed in porcine intestinal
mucosa. We investigated the potential for the cytosolic
broad-speci¢city L-glucosidase to be the enzyme responsible
for the activity observed in the human tissue extracts, by
studying the known inhibitors or activators of the cytosolic
L-glucosidase and the glucocerebrosidase. The results are in
agreement with Daniels et al. [17], which indicate that the
activity is due to the cytosolic L-glucosidase, not a mem-
brane-bound enzyme. Pyridoxine glucoside hydrolase exhibits
a di¡erent pattern of inhibition with conduritol B epoxide and
sodium taurocholate to the broad-speci¢city L-glucosidase,
and to the enzyme active on the £avonoid glycosides in our
tissue samples. It would, therefore, seem likely that the activ-
ity demonstrated by the human small intestine and liver ex-
tracts results from the cytosolic broad-speci¢city L-glucosi-
dase.
The deglycosylation of (iso)£avonoids by human cytosolic
L-glucosidase could be an important ¢rst step in their uptake,
metabolism, excretion and biological activity, which is inde-
pendent of metabolism by the colonic micro£ora. The results
emphasize that many dietary (iso)£avonoid glycosides are de-
glycosylated by enzymes in human tissues. However, the rate
and extent of deglycosylation depends on the structure of the
£avonoid and the position/nature of the sugar substitutions.
The results are important to consider in any future studies of
human metabolism of £avonoid glycosides in vivo.
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Km of various puri¢ed liver L-glucosidase substrates
Substrate Enzyme source Km (mM) Reference
4-Methylumbelliferyl-L-glucoside human 0.062 [17]
p-Nitrophenyl glucoside rabbit 2.1 [16]
17 K-estradiol-3-glucoside rabbit 5U1037 [16]
17 K-estradiol-17-glucoside rabbit 0.039 [16]
17 L-estradiol-17-glucoside rabbit 1.3 [16]
Pyridoxine 5P-glucoside human 2 [21]
L-picein guinea pig 0.63 [18]
Q 4P-glucoside human (crude extract) 0.027 ^
Genistein 7-glucoside human (crude extract) 0.013 ^
Table 3
E¡ect of various inhibitors on L-glucosidase activity
L-Glucosidase Sodium taurocholate Gluconolactone Conduritol B epoxide
(1.2%, w/v) (10 mM) (5 mM)
% of control activity
Glucocerebrosidase [17] 862 49 0c
Broad-speci¢city [17] 16 7 100c
Pyridoxine glucoside hydrolase [22] 79a 0b 30
Human liver cell-free extract 2 0 95
Human small intestine cell-free extract 10 0 83
a1%, w/v; bbased on Ki = 7 WM; c6.2 mM.
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